“I’m on no sleep, no food, fueled only by two bags of complimentary popcorn, Zyns, and my fanaticism for literary greatness, and as the second round of readers begins, things get real ascetic.”
- Recently published preclinical data demonstrate initial proof-of-concept for the therapeutic development of AMX0035 in Wolfram syndrome
. | April 13, 2023
Amylyx Pharmaceuticals, Inc. today announced that Joshua Cohen and Justin Klee, Co-CEOs of Amylyx, will participate in the 22nd Annual Needham Virtual Healthcare Conference. The conference is being. | April 11, 2023